Table 1 Comparisons between GBS patients with and without mechanical ventilation
Variable | Group MV (n = 80) | Group NV (n = 461) | p value |
|---|---|---|---|
Age (years) | 43.8 ± 16.7 | 41.2 ± 15.3 | >0.05 |
Male | 51 (63.8 %) | 280 (60.7 %) | >0.05 |
Antecedent infections | 55 (68.75 %) | 301 (65.3 %) | >0.05 |
Cranial nerve involvement | 53 (66.25 %) | 184 (39.91 %) | <0.05 |
Facial nerve | 43 (81.1 %) | 126 (68.5 %) | <0.05 |
Glossopharyngeal and vagus nerves | 30 (56.6 %) | 50 (27.2 %) | <0.05 |
Oculomotor and/or abducent nerve | 12 (15 %) | 57 (12.4 %) | >0.05 |
Sensory disturbance | 36 (45 %) | 249 (54.0 %) | >0.05 |
Autonomic dysfunction | 7 (8.8 %) | 20 (4.3 %) | >0.05 |
Pain | 7 (8.8 %) | 45 (9.8 %) | >0.05 |
Hyporeflexia or areflexia | 79 (98.8 %) | 434 (94.1 %) | >0.05 |
Hospital stay (days) | 38.7 ± 28.3 | 14.6 ± 6.3 | <0.05 |
Treatment modality | >0.05 | ||
IVIg | 39 (48.8 %) | 216 (46.9 %) | |
IVIg + intravenous corticosteroids | 29 (36.2 %) | 72 (15.6 %) | |
Intravenous corticosteroids | 6 (7.5 %) | 90 (19.5 %) | |
Supportive treatment | 6 (7.5 %) | 83 (18.0 %) |